Visit Confluence at SLAS 2020 Conference, Jan. 25-29, San Diego, CA.
Confluence is exhibiting at SLAS 2020 in San Diego, CA from January 25th, 2020 to January 29th, 2020. Please visit us at booth # 1834.[Read More…]
Visit us at Cambridge Health Institute’s Discovery on Target
The CDT team will be exhibiting at “Cambridge Health Institute’s Discovery on Target” conference Sept 16-19, 2019 in Boston MA. Please be sure to visit us at booth #201.[Read More…]
Confluence Moves to New Office Space
Confluence has completed our move into our new office space in the Cortex Innovation District. Our offices and labs are now located at 4340 Duncan Avenue, Suite 400, St. Louis, MO 63110.[Read More…]
Confluence is Attending 2019 Drug Discovery Chemistry, April 8-12, San Diego, CA
Confluence is attending Cambridge Healthtech Institute’s 14th annual 2019 Drug Discovery Chemistry conference in San Diego CA, April 8-12. Please visit our booth #119.[Read More…]
Visit Confluence at SLAS 2019 Conference, Feb. 2-6, Washington, D.C.
Confluence’s team is attending the SLAS 2019 Conference and Expo. Please visit us at Booth #546. With an expected audience of more than 5,000 top researchers, engineers, academics and other life sciences discovery and technology professionals, SLAS 2019 is focused on Innovation and Application. Come learn about how Confluence can be your research partner from…[Read More…]
Confluence will be attending AACR Annual Meeting 2018, held in Chicago, Illinois, April 14 – 28th
Please visit us at Booth 1637. The focus of this years meeting is “Driving Innovative Cancer Science to Patient Care”. For more information on the meeting please visit the AACR Website. AACR Website[Read More…]
Confluence welcomes William Taylor Ph.D. as Confluence’s new Director of Biochemistry
Dr. Taylor is an accomplished biochemist and drug discovery scientist with a history of providing strategic leadership and critical analyses across multiple target classes & disease areas. Prior to Confluence Discovery Technologies he spent seventeen years at Vertex Pharmaceuticals where he gained extensive experience in bringing small molecules forward from initial screen through hit-to- lead…[Read More…]
Aclaris Therapeutics Acquires Confluence Life Sciences, Inc.
Expands pipeline of medicines for the potential treatment of patients with autoimmune disorders Management to Host Conference Call at 8:30 AM ET today MALVERN, Pa., Aug. 08, 2017 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (“Aclaris”) (NASDAQ:ACRS), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs…[Read More…]
Confluence’s Paul Changelian, Ph.D. and Jon Jacobsen, Ph.D. to Speak at 2017 Society for Investigative Dermatology (SID) Annual Meeting
Confluence’s Paul Changelian, Ph.D. and Jon Jacobsen, Ph.D. are scheduled to speak at 2017 Society for Investigative Dermatology (SID) Annual Meeting that is being held at the Oregon Convention Center in Portland Oregon from 4/26/2017 to 4/29/2017. To learn more out about the meeting or the program of events please click on the image below.[Read More…]